Torthaí cuardaigh - Frédérique Penault‐Llorca

Beachtaigh na torthaí
  1. 1
    Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective

    Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective de réir Frédérique Penault‐Llorca, Giuseppe Viale

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    aHIF but not HIF-1α transcript is a poor prognostic marker in human breast cancer

    aHIF but not HIF-1α transcript is a poor prognostic marker in human breast cancer de réir Anne Cayre, Fabrice Rossignol, Eric Clottes, Frédérique Penault‐Llorca

    Foilsithe / Cruthaithe 2003
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Testing algorithm for identification of patients with TRK fusion cancer

    Testing algorithm for identification of patients with TRK fusion cancer de réir Frédérique Penault‐Llorca, Erin R. Rudzinski, Antonia R. Sepulveda

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells

    Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells de réir Abderrahim El Guerrab, Mahchid Bamdad, Yves‐Jean Bignon, Frédérique Penault‐Llorca, Corinne Aubel

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Treatment of gastric adenocarcinoma: A rapidly evolving landscape

    Treatment of gastric adenocarcinoma: A rapidly evolving landscape de réir Julien Taı̈eb, Jaafar Bennouna, Frédérique Penault-Llorca, Debora Basile, Emmanuelle Samalin, Aziz Zaanan

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Experts' opinion: Recommendations for retesting breast cancer metastases for HER2 and hormone receptor status

    Experts' opinion: Recommendations for retesting breast cancer metastases for HER2 and hormone receptor status de réir Frédérique Penault‐Llorca, Renata A. Coudry, Wedad Hanna, R. Yoshiyuki Osamura, Josef Rüschoff, Giuseppe Viale

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer

    Anti-EGFR monoclonal antibodies and EGFR tyrosine kinase inhibitors as combination therapy for triple-negative breast cancer de réir Abderrahim El Guerrab, Mahchid Bamdad, Fabrice Kwiatkowski, Yves‐Jean Bignon, Frédérique Penault‐Llorca, Corinne Aubel

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up de réir Fátima Cardoso, S. Kyriakides, S. Ohno, Frédérique Penault‐Llorca, Philip Poortmans, Isabel T. Rubio, Sophia Zackrisson, Elżbieta Senkus

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Errata/Corrigenda
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up de réir Elżbieta Senkus, S. Kyriakides, Frédérique Penault‐Llorca, Philip Poortmans, Alastair M. Thompson, Sophia Zackrisson, Fátima Cardoso

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Erratum to “Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”

    Erratum to “Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up” de réir Fátima Cardoso, S. Kyriakides, Shinji Ohno, Frédérique Penault‐Llorca, Philip Poortmans, Isabel T. Rubio, Sophia Zackrisson, Elżbieta Senkus

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Errata/Corrigenda
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up de réir Fátima Cardoso, S. Kyriakides, Shinji Ohno, Frédérique Penault‐Llorca, Philip Poortmans, Isabel T. Rubio, Sophia Zackrisson, Elżbieta Senkus

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers

    Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers de réir Insaf Fkih M’hamed, Maud Privat, Flora Ponelle‐Chachuat, Frédérique Penault‐Llorca, Abderraouf Kénani, Yves‐Jean Bignon

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Leptin and leptin receptor involvement in cancer development: a study on human primary breast carcinoma

    Leptin and leptin receptor involvement in cancer development: a study on human primary breast carcinoma de réir Thierry Jardé, Florence Caldefie-Chézet, Mireille Damez, Florence Mishellany, Frédérique Penault‐Llorca, Jacques Guillot, M.-P. Vasson

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Germline mutations of the E‐cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer

    Germline mutations of the E‐cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer de réir Zeming Xie, Lai Sheng Li, Claire Laquet, Frédérique Penault‐Llorca, Nancy Uhrhammer, Xiao Xie, Yves Jean Bignon

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    SIRT1-dependent epigenetic regulation of H3 and H4 histone acetylation in human breast cancer

    SIRT1-dependent epigenetic regulation of H3 and H4 histone acetylation in human breast cancer de réir Khaldoun Rifaï, Gaëlle Judes, Mouhamed Idrissou, Marine Daures, Yves‐Jean Bignon, Frédérique Penault‐Llorca, Dominique Bernard-Gallon

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Implementing TMB measurement in clinical practice: considerations on assay requirements

    Implementing TMB measurement in clinical practice: considerations on assay requirements de réir Reinhard Büttner, John Longshore, Fernando López‐Ríos, Sabine Merkelbach‐Bruse, Nicola Normanno, Etienne Rouleau, Frédérique Penault‐Llorca

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up de réir Elżbieta Senkus, S. Kyriakides, Shinji Ohno, Frédérique Penault‐Llorca, Philip Poortmans, Emiel J. Rutgers, Sophia Zackrisson, Fátima Cardoso

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study

    Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study de réir Marc J. van de Vijver, Michael Bilous, Wedad Hanna, Manfred Hofmann, Petra Kristel, Frédérique Penault‐Llorca, Josef Rüschoff

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies

    Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies de réir Thierry Jardé, Florence Caldefie-Chézet, Nicolas Gonçalves-Mendes, Florence Mishellany, Christa Buechler, Frédérique Penault‐Llorca, M.-P. Vasson

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Progresses Toward Precision Medicine in<i>RET</i>-altered Solid Tumors

    Progresses Toward Precision Medicine in<i>RET</i>-altered Solid Tumors de réir Carmen Belli, Santosh Anand, Justin F. Gainor, Frédérique Penault‐Llorca, Vivek Subbiah, Alexander Drilon, Fabrice André, Giuseppe Curigliano

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: